Figure 2

Two different examples of high-grade, no-special-type triple-negative breast carcinomas. Case 1 (a–c): Hematoxylin–eosin ( × 20) (a) with strong immunoreactivity for p16 (b) and negativity for Rb (stromal and lymphoid control cells positive) (c). Case 2 (d–f): Hematoxylin–eosin ( × 20) (d) with p16 low (e) and Rb+ (f) immunostaining.